H-1B sponsorship profile: Fulcrum Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Fulcrum Therapeutics, Inc filed 7 Labor Condition Applications covering 7 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 85.7% (6 certified of 7 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Fulcrum Therapeutics, Inc’s H-1B petitions range from $115,000 at the low end to $300,000 at the high end, with a petition-weighted average of $162,857. That range reflects the mix of occupations the company sponsors, led by Senior Manager, Clinical Data Management (2 petitions at $140,000 avg), followed by Senior Biostatistician and Associate Director-Drug Product Development. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Fulcrum Therapeutics, Inc is headquartered in Cambridge, MA under NAICS code 541714, and places H-1B workers across 2 states, most heavily in MA, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Fulcrum Therapeutics, Inc ranks. By H-1B petition volume, Fulcrum Therapeutics, Inc is #21,197 of 119,880 employers nationally and #921 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.